Baupost Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Baupost Group’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,226,839	Closed	-$465K	–	38
2018 Q1	$465K	Hold	2,226,839	–	–	﹤0.01%	33
2017 Q4	$2.87M	Hold	2,226,839	–	–	0.03%	33
2017 Q3	$4.72M	Hold	2,226,839	–	–	0.06%	34
2017 Q2	$6.46M	Hold	2,226,839	–	–	0.07%	38
2017 Q1	$7.66M	Hold	2,226,839	–	–	0.09%	40
2016 Q4	$3.88M	Hold	2,226,839	–	–	0.05%	42
2016 Q3	$7.39M	Sell	2,226,839 -1	-0%	-$4	0.11%	39
2016 Q2	$9.57M	Hold	2,226,840	–	–	0.13%	36
2016 Q1	$12.5M	Buy	2,226,840 +2,000,000	+882%	+$26M	0.18%	30
2015 Q4	$3.9M	Buy	226,840 +144,704	+176%	+$3.45M	0.07%	34
2015 Q3	$1.53M	Buy	+82,136	New	+$2.81M	0.03%	41

Other funds holding OREX

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Baupost Group's OREX Position: Q2 2018 in Review

Baupost Group sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 2,226,839 shares — an estimated $465K sold.

Baupost Group first reported a position in OREX in Q3 2015 and held it in 11 quarters. The position peaked at $12.5M in Q1 2016. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

Baupost Group reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Baupost Group sold 2,226,839 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $465K.
Baupost Group first reported a position in Orexigen Therapeutics, Inc. in Q3 2015 and held it in 11 quarters.
Baupost Group's Orexigen Therapeutics, Inc. position peaked at $12.5M in Q1 2016.
4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Baupost Group's 13F filing for Q2 2018, filed 13 Aug 2018.